Ann Clin Toxicol | Volume 5, Issue 1 | Commentary | Open Access

Buprenorphine and Drug Overdose Deaths

Strickland DM1 * and Gale G2

1Medical Director, Stepping Stone of NC, USA 2University of Missouri–Kansas City, USA

^*Correspondance to: Strickland DM 

Fulltext PDF

Abstract

In the clinical practice of Medication Assisted Treatment (MAT) buprenorphine as a Medication to treat Opioid Use Disorder (MOUD) has an excellent efficacy and safety profile. As a result of such safety and efficacy, the US National Institute on Drug Abuse has identified the medication as a first line treatment for opioid dependence. However, a recent study and others, have questioned such safety, which may have created confusion among legislators and even medical practitioners who are not knowledgeable about the pharmacology of buprenorphine. This article is a review/commentary on the safety of buprenorphine as a MOUD.

Keywords:

Buprenorphine; Opioid; MAT; MOUD; OUD

Citation:

Strickland DM, Gale G. Buprenorphine and Drug Overdose Deaths. Ann Clin Toxicol. 2022;5(1):1036.